Clinical trial
The Role of HSP90 in Peripheral Vascular Lesions of Diabetic Atherosclerosis
NCT04787770 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of HSP90 in Peripheral Vascular Lesions of Diabetic Atherosclerosis
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2020
- Completion date
- December 10, 2020
- Enrollment
- 150 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.